SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 30, 2017
(Exact name of Registrant as specified in its charter)
(State or other jurisdiction of
|20 Florence Avenue, Batavia, New York||14020|
|(Address of principal executive offices)||(Zip Code)|
Registrants telephone number, including area code: (585) 343-2216
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
|☐||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|☐||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|☐||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|☐||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Item 8.01. Other Events.
In March 2017, while it was permissible for executive officers of Graham Corporation (the Company) to purchase and sell securities of the Company, James R. Lines, the Companys President and Chief Executive Officer, entered into a binding pre-arranged stock trading plan (the 10b5-1 Plan). Pursuant to the 10b5-1 Plan, up to 15,000 shares of the Companys common stock held by Mr. Lines will be sold on a periodic basis through December 31, 2017, without further direction from him and in accordance with the terms and conditions set forth in the 10b5-1 Plan. The 10b5-1 Plan was designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, and the Companys Insider Trading Policy.
Transactions made pursuant to the 10b5-1 Plan will be disclosed publicly through Form 4 filings with the Securities and Exchange Commission. Except as may be required by law, the Company does not undertake to report on any specific plans of the Companys officers or directors designed to comply with Rule 10b5-1, nor to report modifications or terminations of the 10b5-1 Plan or any similar plan of any other individual.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
|Date: March 30, 2017||By:||/s/ Jeffrey Glajch|
|Vice President Finance & Administration and|
|Chief Financial Officer|